STOCKHOLDERS’ EQUITY (DEFICIENCY) (Details Narrative) - USD ($)				3 Months Ended			6 Months Ended	12 Months Ended
	Dec. 21, 2021	May 22, 2020	Jan. 09, 2020	Jun. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020	Feb. 02, 2016
Class of Stock [Line Items]
Common Stock, Shares Authorized				125,000,000				125,000,000
Common Stock, Par or Stated Value Per Share								$ 0.001
Preferred Stock, Shares Authorized				10,000,000				10,000,000
Preferred Stock, Par or Stated Value Per Share								$ 0.001
Common Stock, Shares, Issued				50,219,034				49,810,322
Common Stock, Other Shares, Outstanding				1,466,718				1,466,718
Preferred Stock, Shares Outstanding								1
Stock Issued During Period, Shares, Issued for Services								250,000
Stock Issued During Period, Value, Issued for Services				$ 7,500				$ 1,414,449
Proceeds from Issuance of Common Stock							$ 14,545,805
Class of Warrant or Right, Outstanding								658,355	97,500
[custom:ClassOfWarrantOrRightCashlessWarrantExercise-0]								446,370
Proceeds from Warrant Exercises				12,500		$ 146,250
Fair Value Adjustment of Warrants	$ 1,042,149
Share-Based Payment Arrangement, Noncash Expense				$ 149,190		155,851
2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized											3,750,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term										10 years
Share Price										$ 0.974
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture										$ 1,600,515
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				10,180
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term				10 years
Share-Based Payment Arrangement, Noncash Expense				$ 149,190		$ 155,851
Minimum [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price								$ 2.40	$ 0.74	$ 1.40
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term								2 years	2 years	2 years
Minimum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate										0.46%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term										3 years
Maximum [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price								$ 3.98	$ 2.89	$ 2.00
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term								10 years	10 years	3 years
Maximum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate										0.75%
Uplisting Public Stock Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues								5,382,331
Stock Issued During Period, Shares, Conversion of Convertible Securities								69,252
Proceeds from Issuance of Common Stock								$ 14,545,805
Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Number of stock issued during the period convertible, shares								4,696,083
Stock Issued During Period, Shares, Conversion of Convertible Securities								19,263
Repayments of Debt								$ 14,522,812
Convertible Notes Payable				302,000				10,309,000
Debt Instrument, Convertible, Beneficial Conversion Feature				104,118				3,398,557
Unpaid interest amount								815,255
Stock Issued During Period, Value, New Issues								15,678,454
Fair value of stock to be issued								$ 1,155,642
[custom:DebtsInstrumentSettlementAmount]				406,118
Debt Instrument, Fair Value Disclosure				457,026
Loss on conversion of convertible promissory notes				$ 50,908
Series A Notes [Member]
Class of Stock [Line Items]
Number of stock issued during the period convertible, shares				404,545
Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues								658,355
Stock Issued During Period, Shares, Issued for Services								451,688
[custom:StockIssuedDuringPeriodSharesWarrantsExercised]				11,792
[custom:StockIssuedDuringPeriodValueWarrantsExercise]				$ 12,500
Cash receipt amount								$ 872,292
Proceeds from Warrant Exercises								$ 103,950
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture								212,594
Cashless Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues								446,370
Shares To Be Issued [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities						327,274
Stock Issued During Period, Value, Issued for Services
Proceeds from Issuance of Preferred Stock and Preference Stock								$ 250,000
[custom:StockIssuedDuringPeriodSharesWarrantsExercised]				(28,302)		37,736
Issuance of Common Shares [Member]
Class of Stock [Line Items]
[custom:NumberSharesRemovedPreviouslyToBeIssued]				40,094
Issuance of Common Shares [Member] | Minimum [Member]
Class of Stock [Line Items]
Shares Issued, Value, Share-Based Payment Arrangement, Forfeited				$ 42,500
Investors [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues								1,423,260
AdvisorAndConsultantTwoMember | Warrant [Member]
Class of Stock [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture								25,000
Fair Value Adjustment of Warrants								$ 541,443
Executive Officer [Member] | Warrant [Member]
Class of Stock [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture								187,594
Lenders [Member] | Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								57,536
Warrants and Rights Outstanding								$ 198,713
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpirationDate]								Dec. 21, 2028
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price								$ 6.26
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate								1.40%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate								121.71%
Underwriter [Member] | Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								373,404
Warrants and Rights Outstanding								$ 900,371
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpirationDate]								Aug. 26, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price								$ 3.75
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate								0.77%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate								111.90%
Executive [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				53,827
Advisor [Member] | General and Administrative Expense [Member]
Class of Stock [Line Items]
Warrants and Rights Outstanding				$ 77,414
Employee [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term				10 years
Board of Director [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term										10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate										132.20%
Exchange Agreement [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				51,685,752
Exchange Agreement [Member] | 11% Secured Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Conversion of Stock, Description				The outstanding 11% secured convertible promissory notes of iMedical were adjusted, in accordance with the adjustment provisions thereof, as and from closing, so as to permit the holders to convert (and in some circumstances permit the Company to force the conversion of) the convertible promissory notes into shares of the common stock of the Company at a 25% discount to purchase price per share in Biotricity’s next offering
Discount percentage for purchase price per shares				25.00%
Exchange Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 shares of the common stock of the Company for each warrant, with an inverse adjustment to the exercise price of the warrants to reflect the exchange ratio of approximately 1.197:1
Exchange Agreement [Member] | Advisor Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 shares of the common stock of the Company for each advisor warrant, with an inverse adjustment to the exercise price of the Advisor Warrants to reflect the exchange ratio of approximately 1.197:1
Exchange Agreement [Member] | Options [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 economically equivalent replacement options with an inverse adjustment to the exercise price of the replacement option to reflect the exchange ratio of approximately 1.197:1
Exchange Agreement [Member] | Shareholders [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				13,376,947				51,277,040
Common stock exchange description								1.197 shares of its common stock in exchange for each common share of iMedical held by the iMedical shareholders who in general terms, are not residents of Canada (for the purposes of the Income Tax Act (Canada). Accordingly, the Company issued 13,376,947 shares
Exchange Agreement [Member] | Exchangeco [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 Exchangeable Shares in the capital of Exchangeco in exchange for each common share of iMedical held. Accordingly, the Company issued 9,123,031 Exchangeable Shares
[custom:NumberOfExchangeableSharesIssued]				9,123,031
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized				20,000				20,000
Preferred Stock, Par or Stated Value Per Share				$ 0.001				$ 0.001
Stock Issued During Period, Shares, New Issues			6,000		100			288,756
Preferred Stock, Shares Outstanding				6,872				7,201
Proceeds from Issuance of Preferred Stock and Preference Stock		$ 100,000	$ 6,000,000		$ 100,000			$ 100,000
Issuance of preferred shares for private placement investors shares								100